Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 2.
doi: 10.1002/mas.21861. Online ahead of print.

Mass spectrometry in ocular drug research

Eva M Del Amo  1 , Kati-Sisko Vellonen  1 , Arto Urtti  1   2 , Tetsuya Terasaki  1 , Anam Hammid  1 , Paavo Honkakoski  1 , Seppo Auriola  1
Affiliations
Review

Mass spectrometry in ocular drug research

Eva M Del Amo et al. Mass Spectrom Rev. .

Abstract

Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments. The second part of the review consists of an introduction to ocular proteomics, with special emphasis on targeted absolute quantitation of membrane transporters and metabolizing enzymes. The third part of the review deals with liquid chromatography-MS (LC-MS) and MS imaging (MSI) methods used in the analysis of drugs and metabolites in ocular samples. The sensitivity and speed of LC-MS make simultaneous quantitation of various drugs and metabolites possible in minute tissue samples, even though ocular sample preparation requires careful handling. The MSI methodology is on the verge of becoming as important as LC-MS in ocular pharmacokinetic studies, since the spatial resolution has reached the level, where cell layers can be separated, and quantitation with isotope-labeled standards has come more reliable. MS will remain in the foreseeable future as the main analytical method that will progress our understanding of ocular pharmacokinetics.

Keywords: LC-MS/MS; MSI; drug analysis; mass spectrometry; ocular pharmacokinetics; proteomics; quantitation; spatial distribution.

PubMed Disclaimer

References

REFERENCES

    1. Ablonczy Z, Higbee D, Anderson DM, Dahrouj M, Grey AC, Gutierrez D, Koutalos Y, Schey KL, Hanneken A, Crouch RK. 2013. Lack of correlation between the spatial distribution of A2E and lipofuscin fluorescence in the human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 54:5535-5542.
    1. Ablonczy Z, Smith N, Anderson DM, Grey AC, Spraggins J, Koutalos Y, Schey KL, Crouch RK. 2014. The utilization of fluorescence to identify the components of lipofuscin by imaging mass spectrometry. Proteomics. 14:936-944.
    1. Adaway JE, Keevil BG. 2012. Therapeutic drug monitoring and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 883-884:33-49.
    1. Ahmad M, Zhang P, Dufresne C, Ferrucci L, Semba RD. 2018. The human eye proteome project: updates on an emerging proteome. Proteomics, 18:1700394.
    1. Amirpour N, Karamali F, Razavi S, Esfandiari E, Nasr-Esfahani MH. 2014. A proper protocol for isolation of retinal pigment epithelium from rabbit eyes. Adv Biomed Res 3:4.